BERNUZZI, FRANCESCA VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 6.674
AS - Asia 2.798
EU - Europa 2.328
SA - Sud America 435
Continente sconosciuto - Info sul continente non disponibili 389
AF - Africa 90
OC - Oceania 1
Totale 12.715
Nazione #
US - Stati Uniti d'America 6.359
SG - Singapore 1.085
CN - Cina 598
IT - Italia 474
HK - Hong Kong 385
SE - Svezia 377
RU - Federazione Russa 352
BR - Brasile 330
VN - Vietnam 302
CA - Canada 269
DE - Germania 268
IE - Irlanda 258
GB - Regno Unito 122
AT - Austria 106
UA - Ucraina 105
FR - Francia 98
TR - Turchia 78
IN - India 62
BD - Bangladesh 59
AR - Argentina 53
FI - Finlandia 53
IQ - Iraq 32
ID - Indonesia 26
ZA - Sudafrica 26
DK - Danimarca 22
JP - Giappone 22
MY - Malesia 21
PK - Pakistan 21
MX - Messico 19
BE - Belgio 17
ES - Italia 17
DZ - Algeria 14
PH - Filippine 14
KR - Corea 13
NL - Olanda 13
CO - Colombia 11
MA - Marocco 11
SA - Arabia Saudita 10
VE - Venezuela 10
KE - Kenya 9
PL - Polonia 9
TN - Tunisia 9
EC - Ecuador 8
UZ - Uzbekistan 8
LT - Lituania 7
CL - Cile 6
IR - Iran 6
JM - Giamaica 6
JO - Giordania 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CH - Svizzera 5
CR - Costa Rica 5
EG - Egitto 5
KZ - Kazakistan 5
LB - Libano 5
AZ - Azerbaigian 4
EU - Europa 4
IL - Israele 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
RO - Romania 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
MN - Mongolia 3
NG - Nigeria 3
NI - Nicaragua 3
PS - Palestinian Territory 3
TW - Taiwan 3
UY - Uruguay 3
BH - Bahrain 2
BY - Bielorussia 2
CM - Camerun 2
GA - Gabon 2
MK - Macedonia 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
LY - Libia 1
Totale 12.326
Città #
Ann Arbor 696
Singapore 644
Fairfield 604
Ashburn 565
Woodbridge 556
Houston 399
Hong Kong 380
Chandler 335
Wilmington 291
Seattle 266
San Jose 253
Dublin 250
Dearborn 189
Cambridge 183
Toronto 181
Frankfurt am Main 179
Milan 169
New York 150
Jacksonville 136
Santa Clara 129
Beijing 105
Princeton 103
Ho Chi Minh City 99
Vienna 98
Chicago 89
The Dalles 82
Nanjing 74
Hanoi 65
Los Angeles 56
Council Bluffs 55
Lawrence 50
Altamura 48
Lauterbourg 44
Boardman 39
Rome 39
Shanghai 37
São Paulo 34
Lachine 32
Dallas 31
San Diego 27
Moscow 26
Andover 25
Buffalo 25
Ottawa 25
Hefei 23
Nanchang 23
Columbus 20
Tokyo 20
Helsinki 17
Brussels 16
Penang 16
Montreal 15
Johannesburg 14
Rio de Janeiro 14
Guangzhou 13
Hebei 13
Jakarta 13
Jinan 13
London 13
Norwalk 13
Nuremberg 13
Tianjin 13
Atlanta 12
Munich 12
Orem 12
Fremont 11
Salt Lake City 11
Changsha 10
Dhaka 10
Elk Grove Village 10
Figino 10
Hangzhou 10
Seoul 10
Shenyang 10
Baghdad 9
Boston 9
Brooklyn 9
Dong Ket 9
Paris 9
San Mateo 9
Stockholm 9
Tampa 9
Washington 9
Zhengzhou 9
Jiaxing 8
Nairobi 8
Ankara 7
Hải Dương 7
Leawood 7
Mountain View 7
Naples 7
Poplar 7
Belo Horizonte 6
Edmonton 6
Haiphong 6
Kunming 6
Lancaster 6
Lissone 6
Taizhou 6
Tashkent 6
Totale 8.469
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 606
A worldwide cross-ethnic study of quality of life in patients with PBC: Attitude or latitude? 436
Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes 348
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms 347
Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal-7 microRNA 331
Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2−/− mice and human primary sclerosing cholangitis 311
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 302
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 291
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 285
miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation 282
The X-factor in primary biliary cirrhosis: Monosomy X and xenobiotics 275
Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth 265
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 262
Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma 249
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 248
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 248
Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth 247
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth 247
Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis 247
Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion 242
Autoantibodies in patients with interleukin 12 receptor beta 1 deficiency 239
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 239
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 236
MicroRNAs in autoimmunity and inflammatory bowel disease: Crucial regulators in immune response 232
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2–/– mice and human cholangiocarcinoma tumorigenesis 230
Nicotine Promotes Cholangiocarcinoma Growth in Xenograft Mice 229
Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b 228
Comprehensive review of autoantibodies in patients with hyper-IgM syndrome 228
Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle 226
Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2−/− mice 226
Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation 225
Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism 224
A precious metal: Iron, an essential nutrient for all cells 219
Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡ 219
Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: Role for heme oxygenase-1 down-modulation 218
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis 216
Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2−/− mice 213
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice 208
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 207
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls 206
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 206
Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases 203
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease 202
TNF-α polymorphisms in primary biliary cirrhosis: A Northern and Southern Italian experience 200
Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice 199
Therapeutic potential of IL-17-mediated signaling pathway in autoimmune liver diseases 194
DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis 192
Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection 189
Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis 177
Cytokines in the Liver: Cytokine Mechanisms in Liver Health and Disease 163
Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells 131
Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 122
Totale 12.715
Categoria #
all - tutte 42.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022640 0 63 127 66 26 46 31 41 26 37 73 104
2022/20231.171 104 346 89 126 77 185 21 69 104 3 31 16
2023/2024739 23 24 6 60 93 204 146 46 44 11 5 77
2024/20251.584 92 145 130 87 153 42 77 58 167 284 109 240
2025/20263.745 351 193 270 317 477 230 474 211 348 315 295 264
2026/2027209 113 96 0 0 0 0 0 0 0 0 0 0
Totale 12.715